LAMCAK pilot study: urinary cathepsin K as a potential biomarker in lymphangioleiomyomatosis

Marion Pronost1,2,3, Lise Vanderlynden2,3, Fabien Lecaille2,3

  • 1Pulmonology and Respiratory Functional Investigation Department, The University Hospital Center of Tours, Tours, France.

ERJ Open Research
|March 18, 2026
PubMed

Related Concept Videos